Kevin Georgek is an associate in the Competition/Intellectual Property practice group. His practice focuses on patent litigation arising under the Biologics Price Competition and Innovation Act and the Hatch-Waxman Act. Kevin also represents global pharmaceutical companies in post-grant proceedings in the U.S. Patent and Trademark Office and in complex antitrust litigation. Kevin has also participated in due diligence investigations of the intellectual property portfolios of companies as part of various corporate transactions.
During law school, Kevin was the Executive Editor of the Seton Hall Law Review and served as a judicial intern to Chief Judge Gary Sharpe in the Northern District of New York. Before law school, Kevin worked as an operations analyst in the Industrial Operations and Product Supply group at Regeneron Pharmaceuticals.